{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "New York",
      "address_1": "599 W 190th St Ste 1",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and phenolphthalein, two active ingredients that were once marketed in the U.S. but removed due to safety reasons, making this product an unapproved new drug.",
      "address_2": "",
      "product_quantity": "18,678 bottles",
      "code_info": "Lot #: 120514, EXP: 12/2014",
      "center_classification_date": "20130823",
      "distribution_pattern": "Nationwide.  Product was also available for sale via internet",
      "state": "NY",
      "product_description": "Bethel 30 capsules, packaged in 30 count bottles, Distributed by BETHEL INC. New York, New York",
      "report_date": "20130904",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Bethel Nutritional Consulting, Inc",
      "recall_number": "D-921-2013",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "product_type": "Drugs",
      "event_id": "65441",
      "termination_date": "20180627",
      "more_code_info": "",
      "recall_initiation_date": "20130611",
      "postal_code": "10040-3577",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}